FOLR1 and neoplasm: Combined, this evidence suggests that F-PLP/pIL15 can successfully deliver pIL15 to tumor cells via folate and FRα interactions and generate antitumor effects by activating immune cells, inducing tumor cytotoxicity and cellular apoptosis and inhibiting tumor cell proliferation.